In this study, we demonstrated that plasma α-MSH levels in CFS patients were significantly higher than those in normal healthy controls, and that there was a significant negative correlation between α-MSH concentrations and the duration of CFS. This evidence concerns the gene STAMBP and myalgic encephalomeyelitis/chronic fatigue syndrome.